LLY's Options Signal High Conviction at $900 Calls Amid Bullish Fundamentals: Here's How to Play the Breakout
- Eli LillyLLY-- (LLY) surged 1.4% to $810.97, trading above its 30D and 200D moving averages.
- RSI at 40.8 hints at oversold conditions, while call open interest spikes at $900 and $1000 strikes.
- Three major news catalysts—breast cancer drug success, diabetes trial wins, and new lab openings—could fuel further upside.
- The big takeaway: Options data and fundamentals align for a potential breakout above $815.57, with $900 calls as a high-conviction play.
Let’s start with the numbers that scream conviction. The options market is loaded with call open interest at the $900 (5,823 contracts) and $1,000 (2,573) strikes for Friday expiration. That’s not just noise—it’s a bet that LLYLLY-- will punch through its intraday high of $815.57 and keep climbing. Meanwhile, puts at $770 (896 contracts) and $760 (834) show some downside hedging, but the put/call ratio of 0.84 (favoring calls) suggests bulls are in control.
The absence of block trades is telling too. No whale-sized trades to exploit here—just retail and institutional players stacking up calls at those key levels. If you’re a trader, this is a green light to focus on upside setups. The risk? A breakdown below $793.82 (intraday low) could trigger panic, but the 30D support at $754–$756.82 is still a long way off.
Why the News Flow Matches the Options BuzzNow, let’s connect the dots between the options frenzy and the headlines. Eli Lilly’s Verzenio showing a 15% reduction in breast cancer mortality isn’t just a medical win—it’s a revenue catalyst. Add that to the diabetes drug orforglipron hitting its primary endpoint and the new San Diego lab boosting R&D, and you’ve got a triple threat for earnings growth.
Here’s the kicker: Investors are pricing in these wins. The $900 and $1,000 call strikes aren’t just speculative—they’re bets on LLY’sLLY-- ability to sustain momentum through Q3 2025 earnings. The RSI at 40.8 isn’t a red flag; it’s a green light for a rebound. If the stock holds above $803.40 (middle Bollinger Band), the path to $892.19 (upper band) looks increasingly probable.
Actionable Trade Ideas for LLY: Calls, Puts, and Price LevelsLet’s get tactical. For options players, the $900 calls expiring Friday (OI: 5,823) are the most compelling. If LLY breaks above $815.57 (intraday high), these strikes could see explosive gamma. For a safer play, the $820 calls (OI: 701) offer leverage if the stock consolidates near $803.40.
On the stock side, here’s a concrete setup:
- Entry: Buy LLY near $803.40 if it holds above the middle Bollinger Band.
- Stop Loss: Below $793.82 (intraday low).
- Target: Aim for $892.19 (upper Bollinger Band) as a high-probability resistance level.
For downside protection, consider selling the $770 puts expiring next Friday (OI: 685). They’re cheap but could hedge against a sudden dip if the RSI fails to recover.
Volatility on the Horizon: What to WatchThe next 30 days will be critical. LLY’s Q3 2025 earnings call and the ESMO conference in October could amplify the current momentum. If the stock holds above $786.75 (200D MA), the long-term ranging pattern could shift into a bullish trend. But don’t ignore the risks: A drop below $764.19 (100D MA) would invalidate the current setup.
In short, LLY is at a crossroads. The options market is pricing in a breakout, the fundamentals are firing on all cylinders, and technicals suggest a low-risk entry. For traders, this is a rare alignment of factors—capitalize on it before the next wave of news hits.
Final TakeawayEli Lilly’s options activity and news flow paint a clear picture: bulls are in control, and the stock is primed for a move. Whether you’re buying calls at $900 or playing the stock’s support at $803.40, the key is to act before the broader market catches up. Keep an eye on the 200D MA as a psychological floor, and don’t let a minor pullback cloud the bigger picture. This is a stock with momentum—and momentum, when backed by fundamentals, can carry you far.

Focus on daily option trades
Latest Articles
Unlock Market-Moving Insights.
Subscribe to PRO Articles.
Already have an account? Sign in
Unlock Market-Moving Insights.
Subscribe to PRO Articles.
Already have an account? Sign in
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
